Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-08-12 00:00:00 ET · period of report 2025-08-08 · accession 0000950170-25-107510 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-08-12 | 2025-08-08+ | BBIO | HOMCY CHARLES J | Dir | S - Sale | $46.37 | -300.0K | 916.7K | -25% | -$13.91M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-08 | S | D | 58,338 | $46.64 | 966,674 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $46.40 to $46.84 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-08-08 | S | D | 191,662 | $45.87 | 1,025,012 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $45.395 to $46.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-08-11 | S | D | 50,000 | $48.00 | 916,674 | D | — | — |